NUDT10 and cancer: Based on the pharmacogenomic analysis from the CTRP and GDSC databases, we investigated the correlation between NUDT10 mRNA expression and the sensitivity of cancer cells to a broad spectrum of anticancer compounds (Fig 10K,L).